Clinical trial

Combination Osilodrostat and Cabergoline in Cushing's Disease

NCT07603466

StatusENROLLING_BY_INVITATION

Study typeINTERVENTIONAL

Start date2026-05-11

PhasePHASE4

Study timeline

Study start (actual)2026-05-11Date precision: day

Registry last updated2026-05-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cushing Disease Due to Increased ACTH Secretionunresolved

Interventions

osilodrostatDRUG · verified · RxNorm: osilodrostat

osilodrostat and cabergolineDRUG

Sponsors & collaborators

University of Basrahlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07603466 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.